摘要 |
<p>There are provided crystalline forms of the compounds Ph(3-Cl)(5-OCHF2)-(R)CH(OH)C(O)-Aze-Pab(OMe) (Compound A) and Ph(3-Cl)(5-OCHF2)-(R)CH(OH)C(O)-Aze-Pab(OH) (Compound B), pharmaceutical compositions containing them, processes for obtaining them and their use in medical treatment.</p> |